Company / Working Capital per Share
Jade Biosciences, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.67
FY2024
5-year range
$2.67 / $13.97
FY2020-FY2024
Trend
-34.1%
vs FY2023
Sector context
#148 of 208
Health Care
What the data says
At $2.67, Jade Biosciences, Inc.'s working capital per share ranks #148 of 208 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $13.97 in FY2021 to $2.67 in FY2024.
Based on SEC 10-K filings.
2.67 in FY2024 with a 3-year CAGR of -42.4%.
Declined from $5.06 to $2.67 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -42.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#148 of 208 in Health CareTop 71% of 208This company $2.67 Sector average $160.16
▼
-98.3% below sector average
Key checks
Key Insights
- Jade Biosciences, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 34.1% year-over-year.
- Ranks #148 out of 208 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.67 | -34.1% |
| FY2023 | $4.05 | -19.9% |
| FY2022 | $5.06 | -63.8% |
| FY2021 | $13.97 | +16.6% |
| FY2020 | $11.98 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026